NCT05141669
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Novartis Investigational Site East Hanover, New Jersey, United States
Clinical trial condition
Demyelinating Diseases
Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.
2,936 public trials
460 recruiting studies
Demyelinating Diseases trial results
NCT03838770
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- NYU Langone Health New York, United States
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Teva Investigational Site 1332 Birmingham, Alabama, United States
- Teva Investigational Site 1327 Gilbert, Arizona, United States
- Teva Investigational Site 1311 Phoenix, Arizona, United States
- Teva Investigational Site 1326 Fullerton, California, United States
NCT02499900
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Teva Investigational Site 13485 Cullman, Alabama, United States
- Teva Investigational Site 13524 Carmichael, California, United States
- Teva Investigational Site 13478 Atlanta, Georgia, United States
- Teva Investigational Site 13475 Northbrook, Illinois, United States
NCT04231253
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Rennes University Hospital Rennes, France
NCT04027114
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +6 more
- Locations
-
- University of Saskatchewan Saskatoon, Saskatchewan, Canada
NCT03111394
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- [email protected] Los Angeles, California, United States
NCT02792231
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Cullman, Alabama, United States
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Aurora, Colorado, United States
Completed
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
NCT01324232
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Neuropathic Pain, +5 more
- Locations
-
- North Central Neurology Associates PC Cullman, Alabama, United States
- St. Joseph's Hospital Medical Center Phoenix, Arizona, United States
- Alta Bates Summit Medical Center Berkeley, California, United States
- University of California, Irvine Orange, California, United States
NCT04746807
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Kliniken Valens Valens, Switzerland